Why any promise to end dialysis is a warning sign
Quick answer
Patients on dialysis have lost nearly all kidney function, and no clinical evidence shows stem cell infusion can free them from it. Any guarantee of that should be treated as a red flag. What genuinely helps is dialysis adequacy, nutrition, phosphate control and transplant evaluation.
Once dialysis starts, the goal shifts from slowing disease to protecting quality of life and preventing complications such as cardiac disease, anaemia and bone disorders. Money spent on unproven options is money taken from those areas.
There is also a plain technical limit: patients with minimal or no urine output cannot realistically supply a sample for urine-derived cell technologies.
Better questions: is dialysis adequate (Kt/V), are haemoglobin and phosphate in range, and do you qualify for the transplant list? Those change survival far more than experimental options.
No credible clinical evidence supports it; anecdotes typically lack verifiable baselines and follow-up.
Only after individual risk assessment with a nephrologist, understanding the goal is not ending dialysis.
For eligible patients, transplantation clearly outperforms long-term dialysis on quality of life and survival.
Dialysis quality, essential medication, nutrition and reliable transport to sessions all pay off more.
No confirmed data; those symptoms usually respond to dialysis, phosphate and anaemia management.
5 points • reviewed 2026-09-02
Reviewed and last updated: 2026-09-02
5 sources • every claim is traceable
https://www.ehlbio.co.kr
https://www.mfds.go.kr/eng/index.do
https://www.mohw.go.kr/eng/
https://pubmed.ncbi.nlm.nih.gov/
https://www.medicalkorea.or.kr/
Last updated: 2026-09-02 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories